PANTHERx: Prepared for Coronavirus (COVID-19)
The leadership at PANTHERx Rare has been closely monitoring the ongoing developments related to the concerns arising from the impact of Coronavirus (COVID-19). Nothing is more important to us than …
Blog
Blog
PANTHERx Chairman & CEO Featured on Podcast Highlighting Entrepreneurial Business Leaders
PANTHERx Rare Chairman & CEO, Dr. Gordon Vanscoy, shares his experiences identifying opportunities, building businesses, and advancing the rare pharmacy industry on the podcast Going Deep with Aaron Watson. Listen …
PANTHERx® Rare Pharmacy Selected by Blueprint Medicines Corporation to Distribute AYVAKIT™ (avapritinib) for Genomically Defined Patient Population with Rare Cancer, GIST
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Blueprint Medicines Corporation as a very limited distribution partner for breakthrough drug AYVAKIT™ (avapritinib). …
Consistent Rise in Orphan Drug Approvals Brings Doses of Hope to the Rare Disease Community
The end of the decade brought with it an exciting and critical trend for people living with rare diseases. Over the last eight years, the Center for Drug Evaluation and …
PANTHERx® Rare Pharmacy Selected by Harmony Biosciences to Distribute WAKIX® (pitolisant)
PANTHERx® Rare Pharmacy announces that it has been selected by Harmony Biosciences, LLC (Harmony) to distribute WAKIX® (pitolisant). PANTHERx is one of a select few specialty pharmacies providing nationwide access …
PANTHERx Launches Video Series Profiling Patients Living with Rare Diseases
Serving patients with rare, orphan, and devastating conditions is the reason PANTHERx Rare exists. The launch of our new website has created a platform through which we are able to …
PANTHERx® Rare Pharmacy Selected by Alnylam Pharmaceuticals to Distribute GIVLAARI™ (givosiran)
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Alnylam Pharmaceuticals as a very limited distribution partner for the novel drug GIVLAARI™ (givosiran). …
PANTHERx Adds Another Quarter of #1 Patient Satisfaction Results to Impressive History of National Recognitions
Read the Official PANTHERx Press Release. PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by Zitter Health Insights, an …
PANTHERx Rare named first national pharmacy holding an accredited distinction in rare disease
Read the official PANTHERx Press Release. Read the official ACHC Press Release. Pittsburgh, PA — October 2, 2019 — PANTHERx is excited to announce that it is the first pharmacy …
PANTHERx Congratulates Controller Tim Kelly on 2019 CFO of the Year Award
PANTHERx is proud to congratulate our Controller, Tim Kelly, on his recognition as a 2019 Pittsburgh Business Times CFO of the Year honoree. Each year, The Pittsburgh Business Times recognizes …